UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden

Leukemia, 2017-08, Vol.31 (8), p.1825-1827

2017

Volltextzugriff (PDF)

Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia

Leukemia, 2016-07, Vol.30 (7), p.1562-1567

2016

Volltextzugriff (PDF)

Second-generation TKI dasatinib inhibits proliferation of mesenchymal stem cells and osteoblast differentiation in vitro

Leukemia, 2010-07, Vol.24 (7), p.1357-1359

2010

Volltextzugriff (PDF)

Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis

Drugs (New York, N.Y.), 2004-01, Vol.64 (20), p.2315-2343

2004

Volltextzugriff (PDF)

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

The New England journal of medicine, 2017-03, Vol.376 (10), p.917-927

2017

Volltextzugriff (PDF)

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Blood, 2013-08, Vol.122 (7), p.1284-1292

2013

Volltextzugriff (PDF)

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Blood, 2008-04, Vol.111 (8), p.4022-4028

2008

Volltextzugriff (PDF)

Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registry

British journal of haematology, 2021-06, Vol.193 (5), p.915-921

2021

Volltextzugriff (PDF)

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

Blood, 2013-01, Vol.121 (3), p.537-545

2013

Volltextzugriff (PDF)

A transforming growth factor-β1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura

Annals of hematology, 2000-09, Vol.79 (9), p.507-513

2000

Volltextzugriff (PDF)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Leukemia, 2009-06, Vol.23 (6), p.1054-1061

2009

Volltextzugriff (PDF)

Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era

British journal of haematology, 2015-06, Vol.169 (5), p.683-688

2015

Volltextzugriff (PDF)

Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes

British journal of haematology, 1998-06, Vol.101 (3), p.420-424

1998

Volltextzugriff (PDF)

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

Nature medicine, 2003-09, Vol.9 (9), p.1123-1124

2003

Volltextzugriff (PDF)

Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2002-09, Vol.8 (5), p.644-648

2002

Volltextzugriff (PDF)

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

American journal of hematology, 2022-04, Vol.97 (4), p.421-430

2022

Volltextzugriff (PDF)

Increased plasma levels of granzymes in adult patients with chronic immune thrombocytopenia

Thrombosis and haemostasis, 2012-06, Vol.107 (6), p.1182-1184

2012

Volltextzugriff (PDF)

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

The New England journal of medicine, 2003-03, Vol.348 (11), p.994-1004

2003

Volltextzugriff (PDF)

Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass

Intensive care medicine, 2000-02, Vol.26 (2), p.188-194

2000

Volltextzugriff (PDF)

Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

The New England journal of medicine, 2004-01, Vol.350 (2), p.114-124

2004

Volltextzugriff (PDF)

No Increased Prevalence of Malignancies Among First-Degree Relatives of Patients with Chronic Myeloid Leukemia - Data from Population-Based Swedish Registries

BLOOD, 2016-12, Vol.128 (22), p.1896-1896

2016

Volltextzugriff (PDF)

Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemia

Haematologica (Roma), 2008-07, Vol.93 (7), p.1101-1103

2008

Volltextzugriff (PDF)

Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin

Journal of bone and joint surgery. American volume, 1991-04, Vol.73 (4), p.484-493

1991

Volltextzugriff (PDF)

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era – a report from the Swedish CML register

European journal of haematology, 2017-01, Vol.98 (1), p.57-66

2017

Volltextzugriff (PDF)

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Cancer, 2009-02, Vol.115 (3), p.551-560

2009

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(135)
Tagungsberichte
(4)

Erscheinungsjahr

n.n

Thema

Humans
(103)
Life Sciences & Biomedicine
(92)
Science & Technology
(92)
Hematology
(74)
Biological And Medical Sciences
(72)
Clinical Medicine
(72)
Male
(72)
Klinisk Medicin
(71)
Adult
(66)
Female
(66)
Middle Aged
(63)
Medical Sciences
(61)
Aged
(56)
Blood
(45)
Blood Platelets
(37)
Platelet Count
(28)
Aged, 80 And Over
(26)
Hematologi
(26)
Hematologic And Hematopoietic Diseases
(26)
Physiology
(26)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden

Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia

Second-generation TKI dasatinib inhibits proliferation of mesenchymal stem cells and osteoblast differentiation in vitro

Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registry

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

A transforming growth factor-β1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era

Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia A

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

Increased plasma levels of granzymes in adult patients with chronic immune thrombocytopenia

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass

Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

No Increased Prevalence of Malignancies Among First-Degree Relatives of Patients with Chronic Myeloid Leukemia - Data from Population-Based Swedish Registries

Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemia

Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era – a report from the Swedish CML register

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Aktive Filter

Suchergebnisse filtern